BTCY (Biotricity) YoY Rev. per Sh. Growth : -55.93% (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Biotricity YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Biotricity's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was -55.93%.

Biotricity's Revenue per Share for the three months ended in Sep. 2024 was $0.15.

Biotricity YoY Rev. per Sh. Growth Historical Data

The historical data trend for Biotricity's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotricity YoY Rev. per Sh. Growth Chart

Biotricity Annual Data

Trend

Aug15

Dec16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

229.17

128.27

86.69

10.20

20.58

Biotricity Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															19.64	16.96	7.32	-34.49	-55.93

Biotricity YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Biotricity's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Mar. 2024 )
=	(Revenue per Share (A: Mar. 2024 )	-	Revenue per Share (A: Mar. 2023 ))	/	\| Revenue per Share (A: Mar. 2023 ) \|
=	(1.342	-	1.113)	/	\| 1.113 \|
=	20.58 %

Biotricity's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=	(Revenue per Share (Q: Sep. 2024 )	-	Revenue per Share (Q: Sep. 2023 ))	/	\| Revenue per Share (Q: Sep. 2023 )) \|
=	(0.145	-	0.329)	/	\| 0.329 \|
=	-55.93 %

Biotricity YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Biotricity's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotricity Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotricity Inc (OTCPK:BTCY) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

203 Redwood Shores Parkway, Suite 600, Redwood City, CA, USA, 94065

Website

https://www.biotricity.com

Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health.

Executives

Chester P White	director	447 BATTERY STREET, SUITE 230, SAN FRANCISCO CA 94111
Ronald W. Mcclurg	director	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DR, EDEN PRAIRIE MN 55344
David A Rosa	director	10901 RED CIRCLE DRIVE, SUITE 150, MINNETONKA MN 55343
Stephen Salmon	director	1177 HAGEN ROAD, NAPA CA 94558
Patricia J Kennedy	director	275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065
Norman M. Betts	director	275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065
Waqaas Al-siddiq	director, 10 percent owner, officer: CEO and Chairman of the Board	C/O 275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065
John Ayanoglou	officer: Chief Financial Officer	C/O 275 SHORELINE DRIVE, SUITE 150, REDWOOD CITY CA 94065